---
schema_version: "secwatch.filing_event.v1"
accession: "0001842952-22-000050"
form_type: "8-K"
ticker: "CNTX"
cik: "0001842952"
company_name: "Context Therapeutics Inc."
filed_at: "2022-06-03T23:59:59+00:00"
generated_at: "2026-06-25T04:52:48.405590+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Context Therapeutics shareholders ratify CohnReznick as auditor for FY 2022

## Summary
- Annual meeting held June 2, 2022; quorum of 9,161,941 shares (57.38%) present.
- Proposal 1: Ratification of CohnReznick LLP as independent auditor for 2022.
- Votes: 9,144,524 For, 8,877 Against, 8,540 Abstentions; no broker non-votes.
- Auditor appointment for year ending December 31, 2022 approved.

## SEC filing metadata
- accession: 0001842952-22-000050
- form_type: 8-K
- ticker: CNTX
- cik: 0001842952
- company_name: Context Therapeutics Inc.
- filed_at: 2022-06-03T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1842952/000184295222000050/0001842952-22-000050-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1842952/000184295222000050/cntx-20220602.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001842952-22-000050
- JSON: https://secwatch.observer/filing/0001842952-22-000050.json
- Plain text: https://secwatch.observer/filing/0001842952-22-000050.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.